Participants 79 94 3
type 2 diabetes
Participants 272 322 4
may be beneficial in patients with type 2 diabetes
Participants 454 494 4
type 2 diabetic patients remains unknown
Participants 617 710 7
eight patients with type 2 diabetes who were being treated with oral glucose-lowering agents.
